• Search
  • Inquiry
  • Why Us?
  • How It Works

Medical Information

Find information on diseases & conditions, and treatment & procedures

Cancer Therapy
Emergent Notification! (Finding Somebody, Who has Liver Cancer, but could not have treatment yet)


Clinical Trial Notification

This is an interventional study in patients with resectable non-small cell lung cancer who will receive 2 courses of durvalum ab (MEDI4736) in the neo-adjuvant setting, followed by surgery with curative intent. 

Total duration of the study is maximum 42 days (from injection therapeutic dose duravalumab (MEDI4736) to surgery). 



Estimated Study Start Date: April 1, 2019

Estimated Study Completion Date: April 1, 2022

Treatment Fee: Free or Minimum


Eligibility Criteria

Age: 50 years and older

Sex: all

Nationality: all


Must medically proven non-small cell lung cancer patient


If you are interested in, please contact